CATX vs FCX · $280.6M cap vs P/E 38, rev $13.26B
Perspective Therapeutics Inc. (CATX) versus Freeport-McMoran Copper & Gold Inc (FCX) — a side-by-side from cached financials, not a winner call.
Perspective Therapeutics Inc. (CATX) is a medical devices company listed on US.
Freeport-McMoran Copper & Gold Inc (FCX) is a copper company listed on US.
CATX does not have a complete income-statement cache yet.
Latest reported FCX revenue for 2026-06-30 was $13.26B. Net income was $1.86B. FCX currently screens at market cap $67.80B and trailing P/E 38.0.
CATX currently screens at market cap $280.6M. FCX currently screens at market cap $67.80B and trailing P/E 38.0.
Not investment advice. Open the CATX and FCX stock pages for the full models.
Not investment advice.